This compound is primarily utilized in the development of pharmaceuticals, particularly as an intermediate in the synthesis of novel therapeutic agents. Its unique structure, combining a benzoxaborole moiety with a nicotinonitrile group, makes it valuable for designing molecules with potential biological activity. It is often explored in the research of anti-inflammatory, antifungal, and antibacterial drugs due to the known pharmacological properties of benzoxaborole derivatives. Additionally, it may be investigated for its potential use in treating metabolic disorders or as a building block in medicinal chemistry for creating targeted inhibitors of specific enzymes or pathways. Its application is largely confined to preclinical research and drug discovery efforts.